Shrinking P/E Ratio Screen for February

(Watch "The Incredible Shrinking Man" in its entirety here.)

As I promised back in January I'm going to revisit my Shrinking P/E Ratio Screen at the beginning of each month in 2008. That being the case, the purpose of this post is to share the results of the screen as of the beginning of February.

For more information on this screen, you can check out my previous posts on the subject here. In short, this screen pulls companies with nicely growing earnings and revenues but with steadily declining P/E ratios over the previous year. My theory which I've yet to prove is that the stocks that are spit out of this screen may be attractive on average as "value plays". By running this screen each month of 2008 I'm hoping to amass some anecdotal evidence of whether my theory is correct or not. My ultimate goal with this study and with any screening or technical filtering I do is to figure out if I can trade based on my theory.

Click on the image below for the results as of the beginning of February. The screening parameters are shown at the top.




Having run this screen semi-regularly for over a year, the first thing that pops out at me is that Genentech (DNA) is absent from the list for the first time since I created the filter. A tiny bit of research revealed that DNA's P/E ratio actually increased in the past month from 26 to 27, thus knocking it off the list. DNA's rise in P/E ratio was due to an increase in stock price as opposed to a decrease in earnings, by the way. This observation makes me wonder if a stock disappearing from the Shrinking P/E Ratio screen might actually be a sign of a stock bottoming. I'll have to keep an eye on that as well in the coming months.

Three stocks that showed up on the screen in January also appear on the list for February (INFY, TDW, and ZUMZ). The four stocks that fell off the list from January to February- DNA, MSNT, QSII, and AAI- each saw a bounce in its share price which resulted in a higher P/E ratio. I'll have to revisit each of these next month to see if their respective bounces continued.

Another thing I found interesting about the results for February is that the seven stocks on the list represent seven different industries. Often during 2007 when I ran the screen I would see a clump of stocks from the same industry, generally oil-related. This always made sense to me since you often see the stocks of an entire industry rise together or fall together.

For the record, I bought a bit of PSYS on Friday after doing some homework on it. The fundamentals look solid to me and the low $30s looks to be a decent support level for the stock. We'll see how it goes. I'm using a relatively tight stop to limit my losses.

As always, I welcome observations and opinions about what this screen might be telling us. Feel free to comment below.

10 Comments:

Born2Code said...

have you read "The Little Book that Beats the Market" and its associated site at http://www.magicformulainvesting.com/ ?

I think your theory is pretty much a variation on the theory in the book which has been shown to work. However the time span needed is years and not month-to-month.

Trading Goddess said...

Born2Code,

Nice to see a visit from you! :)

How are things with you?

I thought in the past you were solely focusing on IBD stocks. Is that still the case?

Matt said...

Thanks for posting the stock screeners! I just discovered them, so I'm still trying to figure out what parameters I should use...if you could rate the most important factors when analyzing stocks either on the screener or on msn's site, which would you choose?

Thanks!

ivanhoff said...

P/E is just measures investors' confidence in certain company. The confidence is a function of:
1. current market outlook - during market rally, investors are willing to pay more in terms of P/E.
2. sector trend
3. earnings and sales growth

Relatively low and decreasing P/E doesn't necessarily mean better value. More often it indicates change in the investors' sentiment. When the market rallies and the economy is strong, people tend to pay more in terms of P/E. P/E usually rises, following an earnings' surprise. It tends to accelerate with every other surprise. When a company doesn't meet the estimates, the P/E coefficient drops to one more sustainable level.

Anonymous said...

PSYS recently broke the 3 yr long term trend support..I wont recommend it till it breaks it again....

Born2Code said...

thanks TG,
all is well. I am solely focused on what makes money :)

I am finding that for me that means long term trend following.
On the long side the stocks I follow typically have their breakout before they make it to the IBD100 but they definitely fit the CANSLIM mold.

On the short side the IBD 100 provides a great resource. Many of its alumnus break down hard and provide great longish-term shorts.

Bullish Jim said...

"On the short side the IBD 100 provides a great resource. Many of its alumnus break down hard and provide great longish-term shorts."

Truer words have never been spoken.

Trading Goddess said...

Anonymous,

"I wont recommend it till it breaks it again...."

It would be terrific if you would share with us "who" you are. A name... moniker...?

Thanks in advance.

Trading Goddess said...

Born2Code,

I would be interested in hearing your screening strategy for stocks that typically breakout before IBD gets their hands on them.

Would you care to share?

And I agree with Jim's comment to yours about the short side. I think a lot of people get misguided because IBD is called afterall Investor's Business Daily, and those that just follow the paper are not savvy to the fact that those stocks get sold when momentum jumps ship. The word Investor's is misleading imo.

At any rate, again... it is good to see you around. :)

Trading Goddess said...

Ivanhoff,

Thanks for your comments. It reminded me to go re-read Ken Fishe's thoughts on high P/E's. Course, he said that 2 years ago, so it would be interesting to see if he has changed his mind since then. hehe

Post a Comment